| Brett S Fissel, MD | |
|
1600 Horizon Dr, Suite 117, Chalfont, PA 18914-4100 | |
| (215) 997-9737 | |
| (215) 997-9738 |
| Full Name | Brett S Fissel |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 29 Years |
| Location | 1600 Horizon Dr, Chalfont, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215970694 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD063970L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jefferson Health Home Care And Hospice | Willow grove, PA | Home health agency |
| Doylestown Hospital | Doylestown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Abington Memorial Hospital | 3274437736 | 528 |
News Archive
Each year, over 300,000 people die of African sleeping sickness (trypanosomiasis). Researchers from the Flanders Interuniversity Institute for Biotechnology (VIB) connected to the Free University of Brussels are making strides in the battle against this disease.
The efficacy of Uganda's HIV prevention programs is decreasing because a new generation of young people are no longer receiving the messages of fidelity that helped curb the country's HIV epidemic in the late 1980s and early 1990s, the Washington Post reports.
ATS Medical, Inc., manufacturer and marketer of state-of-the-art cardiac surgery products and services today announced it has received CE Mark approval to distribute the ATS 3f Enable® Aortic Bioprosthesis in the European Union, indicating it is compliant with relevant European health, safety, and environmental protection legislation.
Northwest Biotherapeutics, Inc. today announced further long-term follow-up data, for the period from January through September 2009, from its prior Phase I and Phase I/II clinical trials conducted at UCLA with DCVax®-Brain in patients with Glioblastoma multiforme ("GBM"). GBM is the most rapid and lethal type of brain cancer. During the update period, only one of the twenty patients treated with DCVax®-Brain (in addition to standard of care) died, and that patient had survived for nearly 7 years (80.5 months).
An assay that identifies a peculiar but important abnormality in cancer cells has been developed and validated by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
› Verified 6 days ago
| Entity Name | Abington Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376812230 PECOS PAC ID: 3274437736 Enrollment ID: O20120208000372 |
News Archive
Each year, over 300,000 people die of African sleeping sickness (trypanosomiasis). Researchers from the Flanders Interuniversity Institute for Biotechnology (VIB) connected to the Free University of Brussels are making strides in the battle against this disease.
The efficacy of Uganda's HIV prevention programs is decreasing because a new generation of young people are no longer receiving the messages of fidelity that helped curb the country's HIV epidemic in the late 1980s and early 1990s, the Washington Post reports.
ATS Medical, Inc., manufacturer and marketer of state-of-the-art cardiac surgery products and services today announced it has received CE Mark approval to distribute the ATS 3f Enable® Aortic Bioprosthesis in the European Union, indicating it is compliant with relevant European health, safety, and environmental protection legislation.
Northwest Biotherapeutics, Inc. today announced further long-term follow-up data, for the period from January through September 2009, from its prior Phase I and Phase I/II clinical trials conducted at UCLA with DCVax®-Brain in patients with Glioblastoma multiforme ("GBM"). GBM is the most rapid and lethal type of brain cancer. During the update period, only one of the twenty patients treated with DCVax®-Brain (in addition to standard of care) died, and that patient had survived for nearly 7 years (80.5 months).
An assay that identifies a peculiar but important abnormality in cancer cells has been developed and validated by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brett S Fissel, MD 1600 Horizon Dr, Suite 117, Chalfont, PA 18914-4100 Ph: (215) 997-9737 | Brett S Fissel, MD 1600 Horizon Dr, Suite 117, Chalfont, PA 18914-4100 Ph: (215) 997-9737 |
News Archive
Each year, over 300,000 people die of African sleeping sickness (trypanosomiasis). Researchers from the Flanders Interuniversity Institute for Biotechnology (VIB) connected to the Free University of Brussels are making strides in the battle against this disease.
The efficacy of Uganda's HIV prevention programs is decreasing because a new generation of young people are no longer receiving the messages of fidelity that helped curb the country's HIV epidemic in the late 1980s and early 1990s, the Washington Post reports.
ATS Medical, Inc., manufacturer and marketer of state-of-the-art cardiac surgery products and services today announced it has received CE Mark approval to distribute the ATS 3f Enable® Aortic Bioprosthesis in the European Union, indicating it is compliant with relevant European health, safety, and environmental protection legislation.
Northwest Biotherapeutics, Inc. today announced further long-term follow-up data, for the period from January through September 2009, from its prior Phase I and Phase I/II clinical trials conducted at UCLA with DCVax®-Brain in patients with Glioblastoma multiforme ("GBM"). GBM is the most rapid and lethal type of brain cancer. During the update period, only one of the twenty patients treated with DCVax®-Brain (in addition to standard of care) died, and that patient had survived for nearly 7 years (80.5 months).
An assay that identifies a peculiar but important abnormality in cancer cells has been developed and validated by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
› Verified 6 days ago
Megan Punches Zakarewicz, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 Horizon Dr, Chalfont, PA 18914 Phone: 215-453-2669 Fax: 215-453-2677 | |
Dr. James Lee Ferguson Jr., D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 Highpoint Dr, Suite 102, Chalfont, PA 18914 Phone: 800-732-3784 | |
Dr. Martin Brian Getzow, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1700 Horizon Dr, Ste 203, Chalfont, PA 18914 Phone: 215-997-0890 Fax: 215-997-9652 | |
Mario O Napoletano, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1600 Horizon Dr, Suite 117, Chalfont, PA 18914 Phone: 215-997-9737 Fax: 215-997-9738 | |
Alan Baseman, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 111 Harrison Forge Court, Chalfont, PA 18914 Phone: 215-325-2624 | |
Dr. Joseph Martin Shaeffer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 202 N Main St, Chalfont, PA 18914 Phone: 215-822-3113 Fax: 215-822-0889 |